Beckman Coulter Life Sciences Revisits the Applications of Counterflow Centrifugal Elutriation

Share Article

In this webinar, which LabRoots will host August 17, participants will gain a greater understanding of the role counterflow centrifugal elutriation (CCE) plays in providing unique knowledge and scientific breakthroughs in several research areas.

Anisha Rathi Post-doctoral Research Associate, Cell and Molecular Biology, St Jude Children's Research Hospital

Presented as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual Event, this webinar is aimed at describing the technique of counterflow centrifugal elutriation and how a wide range of scientific areas can apply this tool to advance their investigations.

CCE is a well-known technique used commonly several decades ago in scientific research. In this technique, cells are subjected to two opposing forces, centrifugal force and fluid velocity, which results in the separation of cells by size and density. With the advent of more sophisticated and automated technologies, the technique of CCE has taken a back-seat.

There is a need to revive this technology in order to benefit the most from its unique capabilities. This technique is especially helpful in studying aspects of primary acute lymphoblastic leukemia cells. The limitations of the technique will also be discussed. The detailed methodology presented should facilitate application and exploration of the technique to other types of cells.

The team at Beckman Coulter Life Sciences has arranged to have Dr. Anisha Rathi, a post-doctoral research associate at St Jude Children's Research Hospital, as the speaker for this event.

After completing a Master's degree in virology, Rathi went on to earn a doctorate in biochemistry and molecular biology from the University of Arkansas for Medical Sciences. In July 2016 she joined the laboratory at St. Jude Children's Research Hospital for a postdoctoral position, where she works on the development of anti-cancer strategies in hematological and solid tumors. Her current research mainly focusses on targeting anti-apoptotic BCL-2 family proteins as a strategy to improve survival in ALL and neuroblastoma.

LabRoots will host the event August 17, 2017, beginning at 10:00 a.m. PDT, 1:00 p.m. EDT. To learn more details on this webinar or to register for free, click here.

About Beckman Coulter:
Beckman Coulter serves customers in two segments: Diagnostics and Life Sciences. The company develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. More than 275,000 Beckman Coulter systems operate in both Diagnostics and Life Sciences laboratories on seven continents. Scientists use Beckman Coulter’s Life Science research instruments to study complex biological problems, including causes of disease and potential new therapies or drugs.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website